Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by jfm1330

T.TH

RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Thanks for your good words and thoughts SPCEO. I hope you are recovering well...

May 25, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

I don't know if they can attract a partner. That being said, a big pharma...

May 25, 2024

T.TH

RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

The strong scientific rationale was there from the beginning. A company with...

May 25, 2024

T.TH

RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

If all they have on humans is stable disease, even on half of the patients...

May 24, 2024

T.TH

RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Hey, I wrote something just as you were posting this. Some telepathy I guess!...

May 24, 2024

T.TH

RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Stable disease for many years is a very good outcome on advanced patients...

May 24, 2024

T.TH

RE:Giving their best shot

They clearly hope to be able to package clinical results of the actual phase...

March 28, 2024

T.TH

RE:RE:Cancer stem cells also called cancer initiating cells

I have no trust left for this management team, but hey, I am stuck in, so I...

March 24, 2024

T.TH

RE:RE:RE:New Press Release - Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

You don't talk about looking for partnership if you are sure it will fail...

March 21, 2024

T.TH

RE:RE:RE:JFM - How is your 2024 starting off?

I am glad that finally a doctor was competent enough to save you. If you...

January 18, 2024

T.TH

RE:JFM - How is your 2024 starting off?

Hi SPCEO Thanks for caring about my situation. I am still on the same chemo...

January 17, 2024

T.TH

RE:RE:RE:RE:Billion dollar deal

No. Thera is a Canadian company, but none of the two drugs it owns is sold in...

January 7, 2024

T.TH

RE:RE:Price to sale ratio in Biotechs

As I said, it was a dumb decision to do a phase I on TH0318 with exenatide so...

December 5, 2023

T.TH

RE:RE:RE:RE: GLP-1 receptor agonist

Not at all, semaglutide (Ozempic) is a much better GLP-1 analog than what...

December 5, 2023

T.TH

RE:RE: GLP-1 receptor agonist

They stopped it after phase I because they were already behind many other...

December 5, 2023

T.TH

RE:The next screwing

No. The stock options they got at much higher SP are now worthless unless...

November 2, 2023

T.TH

RE:0.80 usd / 1.10 cad. Cash per share

The real picture is when you take into account the debt. Greenviolino wrote:...

November 1, 2023

T.TH

RE:RE:RE:Consider this

Saw my oncologist yesterday for the result of my last Ga68 scan, it's...

October 26, 2023

T.TH

RE:Consider this

You cannot add the new oney and not the new shares. So market cap is around...

October 26, 2023

T.TH

RE:1$US

Finally the Levesque era is a disaster. He failed on everything he was...

October 26, 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Tribe Property Technologies Inc.

Tribe Property Technologies Inc. V.TRBE

Tribe Property Technologies Inc. is a property technology company. The Company offers technology-enabled property management ... view more »